• FDA grants fast track designation to peptide-based peanut immunotherapy

    Healio
    24 August 2026

    Read news

  • Eight biotech companies in Melbourne you should know about

    Labiotech
    17 August 2026

    Read story

  • A Different Approach to Food Allergy 

    Food Allergy Fund
    15 August 2026

    Read story

  • Aravax’s PVX108 wins FDA Fast Track designation for peanut allergy

    DiscoverPharma
    3 August 2026

    View news

  • Aravax’s Allergy Shot Gains FDA Fast Track, Fueling Race for a Cure

    BriefGlance
    3 August 2026

    View news

  • Next-Generation Peanut Allergy Therapy Earns FDA Fast Track Designation

    SnackSafely
    3 June 2026

    View news

  • Aravax Future of Allergy Immunotherapy: Next generation food allergy treatment –
    it’s not just a question of efficacy 

    Pascal Hickey PhD, CEO, Aravax
    12 May 2026

    Read article

  • Eight allergy companies to watch in 2026

    Labiotech
    April 15 2026

    Read story [behind a paywall]

  • Food Allergy Treatment Market Is Set to Triple — What it Means for Patients

    SnackSafely.com
    9 April 2026

    Read story

  • Aravax Strengthens Board with Allergy Industry Experts

    Startup Researcher
    9 April 2026

    Read story

  • Aravax adds allergy specialists to board as peanut therapy advances

    Discover Pharma
    8 April 2026

    Read story

  • Scrip Asks… What Does 2026 Hold For Biopharma?

    Scrip
    6 February 2026

    Read article

  • Science: The World’s Shared Language That Carried One Founder Across Continents

    Brandon Biocatalyst
    30 November 2025

    Read story

  • Aravax has appointed Louise Peacock as Chief Regulatory and Quality Officer

    PharmaTimes
    18 June 2025

    View news

  • Australia based Aravax is building out late stage manufacturing capabilities in Oxford, UK

    BiotechTV
    21 February 2025

    Watch here

  • Biotech Aravax establishes UK subsidiary at Oxford Science Park

    Insidermedia
    15 November 2024

    View news

  • Aravax Establishes Pharmaceutical Development Base on the Oxford Science Park With a Focus on Developing Manufacturing Capabilities in the UK

    Drug Development & Delivery
    14 November 2024

    View news

  • Aravax’s Phase 2 Study Now Enrolling Children with Peanut Allergy

    SnackSafely.com
    21 May 2024

    View article

  • Aravax secures US$22M to close series B for peanut allergy therapy

    BioWorld
    29 January 2024

    View news [behind a paywall]

  • Groundbreaking peanut allergy therapy

    Food & Beverage Industry News
    25 January 2024

    View news

  • Aravax raises AU$66m for peanut allergy cure as Victoria leads the way

    Business News Australia
    24 January 2024

    View news

  • Made In Victoria: A Groundbreaking Peanut Allergy Therapy

    victoria.gov.au
    23 January 2024

    View news

  • Could this peanut allergy drug open up a US$4 billion market?

    Forbes
    1 September 2023

    View article

  • Precise, safe, and convenient immunotherapies for food allergy 

    Food Allergy Food Summit 2023
    20 April 2023

    Watch video

  • Aravax raises US$20M series B round to take peanut allergy immunotherapy to phase II

    BioWorld
    27 December 2022

    View news [behind a paywall]

  • Celebrating Scientists and Researchers – Dr Sara Prickett

    Australian Food Allergy Foundation
    26 January 2017

    View video